Atea Pharmaceuticals Inc (AVIR)
Statistics
Key valuation multiples, financial performance ratios, profitability metrics, and per share data consolidated into a single structured view. Each metric is benchmarked against both industry and sector averages — providing immediate context on whether the company is trading at a premium or discount relative to its direct peers and the broader market segment.
Valuation & Market Metrics
Market Capitalization
414,658,000
EV to revenue ratio (TTM)
58.97
EV to ebitda
-260.47
Financial Performance
Revenue (TTM)
192,180,000
Gross profit (TTM)
-155,115,008
EBITDA
-182,858,000
Profitability
Operating margin (TTM)
0.00%
Profit margin
0.00%
Return on assets (TTM)
-36.70%
Return on equity (TTM)
-58.10%
Per Share Metrics
Revenue per share (TTM)
2.31
EPS
-2.08
Diluted EPS (TTM)
-2.08
Book value
2.55
Dividend per share
Dividend yield
Valuation Multiples
P/E ratio
Trailing P/E
Forward P/E
PEG ratio
Price to sales ratio (TTM)
1.553
Price to book ratio (TTM)
2.076
Growth
Quarterly earnings growth (YoY)
295.20%
Quarterly revenue growth (YoY)
264.10%
Analyst Sentiment
Strong buy
0
Buy
2
Hold
1
Sell
0
Strong sell
0
Risk & Volatility
Beta
0.285